Brokerages Set Fresenius Medical Care AG & Co. KGaA (ETR:FME) Price Target at €82.95

Shares of Fresenius Medical Care AG & Co. KGaA (ETR:FME) have been assigned a consensus recommendation of “Buy” from the sixteen analysts that are presently covering the firm, MarketBeat.com reports. Six investment analysts have rated the stock with a hold rating and ten have given a buy rating to the company. The average 1-year price target among brokers that have covered the stock in the last year is €82.95 ($97.58).

FME has been the subject of a number of recent analyst reports. Credit Suisse Group set a €81.00 ($95.29) target price on shares of Fresenius Medical Care AG & Co. KGaA and gave the company a “neutral” rating in a research note on Tuesday, August 25th. Deutsche Bank set a €100.00 ($117.65) price objective on shares of Fresenius Medical Care AG & Co. KGaA and gave the stock a “buy” rating in a research note on Friday, July 31st. Nord/LB set a €82.00 ($96.47) price objective on shares of Fresenius Medical Care AG & Co. KGaA and gave the stock a “buy” rating in a research note on Thursday, August 6th. Sanford C. Bernstein set a €69.50 ($81.76) price objective on shares of Fresenius Medical Care AG & Co. KGaA and gave the stock a “neutral” rating in a research note on Friday, August 7th. Finally, JPMorgan Chase & Co. set a €94.80 ($111.53) price objective on shares of Fresenius Medical Care AG & Co. KGaA and gave the stock a “buy” rating in a research note on Thursday, July 30th.

Shares of FME opened at €72.56 ($85.36) on Friday. The firm has a market capitalization of $22.10 billion and a P/E ratio of 16.44. Fresenius Medical Care AG & Co. KGaA has a 12-month low of €53.50 ($62.94) and a 12-month high of €81.10 ($95.41). The company has a current ratio of 1.02, a quick ratio of 0.68 and a debt-to-equity ratio of 101.16. The firm has a fifty day moving average price of €73.02 and a 200-day moving average price of €71.08.

About Fresenius Medical Care AG & Co. KGaA

Fresenius Medical Care AG & Co KGaA, a kidney dialysis company, provides dialysis care and related services, and other health care services in Germany, the United States, and internationally. It offers dialysis treatment and related laboratory and diagnostic services through a network of outpatient dialysis clinics; materials, training, and patient support services comprising clinical monitoring, follow-up assistance, and arranging for delivery of the supplies to the patient's residence; and dialysis services under contract to hospitals in the United States for the hospitalized end-stage renal disease (ESRD) patients and for patients suffering from acute kidney failure.

See Also: Is a Roth IRA right for you?

Analyst Recommendations for Fresenius Medical Care AG & Co. KGaA (ETR:FME)

Receive News & Ratings for Fresenius Medical Care AG & Co. KGaA Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Fresenius Medical Care AG & Co. KGaA and related companies with MarketBeat.com's FREE daily email newsletter.